Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

NCT01818076 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
311
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision to terminate study (not due to safety reasons)

Conditions

Interventions

Sponsor

Revance Therapeutics, Inc.